ERBB2 and breast carcinoma: For example, in HER2-driven breast cancer, downregulation of integrin α3β1 not only reduced the survival of mice, but also increased tumor growth and vascularization, resulting in an increased burden of lung metastasis (Ramovs et al., 2019).